Nueclear Web Banner
Users Online: 279
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2015  |  Volume : 4  |  Issue : 4  |  Page : 163-173

Recurrent Glioblastoma: Where we stand

Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India

Date of Web Publication8-Feb-2016

Correspondence Address:
Sanjoy Roy
Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal
Login to access the Email id

Source of Support: Phase II and III rct/non rct study; PubMed; 2004-2011., Conflict of Interest: None

DOI: 10.4103/2278-330X.175953

Rights and Permissions

How to cite this article:
Roy S, Lahiri D, Maji T, Biswas J. Recurrent Glioblastoma: Where we stand. South Asian J Cancer 2015;4:163-73

How to cite this URL:
Roy S, Lahiri D, Maji T, Biswas J. Recurrent Glioblastoma: Where we stand. South Asian J Cancer [serial online] 2015 [cited 2018 Mar 22];4:163-73. Available from:

This article has been retracted for infringement of copyright and code of ethics.

This article has been cited by
1 Localized targeted antiangiogenic drug delivery for glioblastoma
Gregory D. Arnone,Abhiraj D. Bhimani,Tania Aguilar,Ankit I. Mehta
Journal of Neuro-Oncology. 2018;
[Pubmed] | [DOI]
2 Advances in Brain Tumor Surgery for Glioblastoma in Adults
Montserrat Lara-Velazquez,Rawan Al-Kharboosh,Stephanie Jeanneret,Carla Vazquez-Ramos,Deependra Mahato,Daryoush Tavanaiepour,Gazanfar Rahmathulla,Alfredo Quinones-Hinojosa
Brain Sciences. 2017; 7(12): 166
[Pubmed] | [DOI]
3 Validation of an established prognostic score after re-irradiation of recurrent glioma
Kerstin A. Kessel,Josefine Hesse,Christoph Straube,Claus Zimmer,Friederike Schmidt-Graf,Jürgen Schlegel,Bernhard Meyer,Stephanie E. Combs
Acta Oncologica. 2017; : 1
[Pubmed] | [DOI]
4 Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection
C. Bastiancich,J. Bianco,K. Vanvarenberg,B. Ucakar,N. Joudiou,B. Gallez,G. Bastiat,F. Lagarce,V. Préat,F. Danhier
Journal of Controlled Release. 2017;
[Pubmed] | [DOI]
5 A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
Lei Yin,Heng Li,Wenjian Liu,Zhenglin Yao,Zhenzhen Cheng,Huabei Zhang,Hui Zou
European Journal of Medicinal Chemistry. 2017;
[Pubmed] | [DOI]
6 Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug
Sheng Zhong,Bo Wu,Xuechao Dong,Yujuan Han,Shanshan Jiang,Ying Zhang,Yang Bai,Sean X. Luo,Yong Chen,Huimao Zhang,Gang Zhao
World Neurosurgery. 2017;
[Pubmed] | [DOI]
7 Recurrent glioblastoma: a single-institution experience with reirradiation and temozolomide
Tejinder Kataria,Deepak Gupta,Ratika Gupta,Shikha Goyal,Shyam Singh Bisht,Trinanjan Basu,Ashu Abhishek,Kushal Narang,Susovan Banerjee
Journal of Radiation Oncology. 2017;
[Pubmed] | [DOI]
8 Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
Benxu Cheng,Liza Doreen Morales,Yonghong Zhang,Shizue Mito,Andrew Tsin,Salvatore V Pizzo
PLOS ONE. 2017; 12(9): e0184324
[Pubmed] | [DOI]
9 Randomized Trial for Short-Term Radiation Therapy With Temozolomide in Elderly Patients With Glioblastoma
David J. McCarthy,Ricardo J. Komotar,Robert M. Starke,E. Sander Connolly
Neurosurgery. 2017; 81(3): N21
[Pubmed] | [DOI]
10 Harnessing nanomedicine for therapeutic intervention in glioblastoma
Anna Gutkin,Zvi R. Cohen,Dan Peer
Expert Opinion on Drug Delivery. 2016; : 1
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded593    
    Comments [Add]    
    Cited by others 10    

Recommend this journal